Neal Rouzier, MD videos
VideoDemo archiveWorldLink source37 min

Hormones and Cancer: Evidence vs. Myth

Dr. Neal Rouzier

Oncology concerns, population data, and how to counsel patients on hormone therapy and malignancy risk.

Recording embedded from WorldLink Medical on YouTube. Public YouTube archive. Demo embed until licensed seminar recordings are hosted here.

Hormones & Cancer
SourceWorldLink Medical· YouTube

Public YouTube archive. Demo embed until licensed seminar recordings are hosted here.

Transcript

0:0037:00

Hormones and cancer is the conversation that stops many physicians from prescribing — and stops many patients from getting relief. We must separate population statistics from the woman or man in front of us. Early WHI-era messaging created decades of oversimplified fear. Contemporary data are more nuanced: timing of initiation, route, dose, progesterone exposure, and baseline risk matter. Absolute risk changes are often small but emotionally amplified. I do not dismiss oncology concerns. I contextualize them. Family history, prior malignancy, imaging, and shared decision-making are non-negotiable. Our responsibility is to cite the best available evidence, explain uncertainty, and never promise zero risk — or pretend risk is infinite.